Profound Medical reported a significant revenue surge in Q3 2025, with an 87% year-over-year increase, reaching $5.3 million. The company also narrowed its net loss to $8 million, or $0.26 per share, ...
Treace Medical Concepts Inc. (TMCI) reported its Q3 2025 financial results, showing an 11% year-over-year revenue growth to $50.2 million. Despite this growth, the company posted a net loss of $16.3 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する